As the LIMK1-mediated cofilin pathway appeared to modulate retinoid receptor functionality, the role of LIM kinases in the survival of patients treated with AML-stabilizing therapy requires further investigations [102]. The gene discussed is LIMK1; the disease is acute myeloid leukemia.